We are live on !
Find out more
Aptevo Therapeutics
APVO
APVO
hedge funds and large institutions have $4.76M invested in Aptevo Therapeutics in 2022 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.68% more ownership
Funds ownership: 15.53% → 16.21% (+0.68%)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $42K
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$25K |
| 2 |
ACT Capital Management
Wayne,
Pennsylvania
|
-$12K |
| 3 |
Total Clarity Wealth Management
St. Charles,
Illinois
|
-$4K |
| 4 |
Truvestments Capital
Sarasota,
Florida
|
-$1K |